- Home
- HSDT vs SXTP Comparison
HSDT vs SXTP Comparison
Compare HSDT & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- SXTP
- Stock Information
- Founded
- HSDT 2014
- SXTP 2010
- Country
- HSDT United States
- SXTP United States
- Employees
- HSDT N/A
- SXTP N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- HSDT Health Care
- SXTP Health Care
- Exchange
- HSDT Nasdaq
- SXTP Nasdaq
- Market Cap
- HSDT 1.8M
- SXTP 1.6M
- IPO Year
- HSDT N/A
- SXTP 2023
- Fundamental
- Price
- HSDT $0.47
- SXTP $0.94
- Analyst Decision
- HSDT Buy
- SXTP Hold
- Analyst Count
- HSDT 2
- SXTP 1
- Target Price
- HSDT $24.00
- SXTP N/A
- AVG Volume (30 Days)
- HSDT 116.7K
- SXTP 87.9K
- Earning Date
- HSDT 11-12-2024
- SXTP 11-26-2024
- Dividend Yield
- HSDT N/A
- SXTP N/A
- EPS Growth
- HSDT N/A
- SXTP N/A
- EPS
- HSDT N/A
- SXTP N/A
- Revenue
- HSDT $502,000.00
- SXTP $462,612.00
- Revenue This Year
- HSDT $16.41
- SXTP $267.05
- Revenue Next Year
- HSDT $31.97
- SXTP $181.82
- P/E Ratio
- HSDT N/A
- SXTP N/A
- Revenue Growth
- HSDT N/A
- SXTP 12.07
- 52 Week Low
- HSDT $0.37
- SXTP $0.70
- 52 Week High
- HSDT $9.50
- SXTP $18.36
- Technical
- Relative Strength Index (RSI)
- HSDT 39.76
- SXTP 47.11
- Support Level
- HSDT $0.44
- SXTP $0.87
- Resistance Level
- HSDT $0.58
- SXTP $1.14
- Average True Range (ATR)
- HSDT 0.06
- SXTP 0.12
- MACD
- HSDT 0.00
- SXTP 0.02
- Stochastic Oscillator
- HSDT 4.17
- SXTP 53.88
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.